Generali Investments Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.35M Buy
32,881
+3,127
+11% +$729K 1.81% 10
2026
Q1
$7.27M Sell
29,754
-3,345
-10% -$779K 1.69% 14
2025
Q4
$6.85M Buy
33,099
+1,644
+5% +$325K 1.36% 16
2025
Q3
$5.83M Buy
31,455
+13,108
+71% +$2.25M 1.22% 15
2025
Q2
$2.8M Sell
18,347
-3,183
-15% -$489K 0.63% 39
2025
Q1
$3.57M Sell
21,530
-1,665
-7% -$261K 1.02% 22
2024
Q4
$3.35M Buy
+23,195
New +$3.59M 0.87% 30

Other funds holding JNJ

Generali Investments Management's JNJ Position: Q2 2026 in Review

Generali Investments Management increased its Johnson & Johnson (JNJ) stake by 11% in Q2 2026, buying an estimated $729K and bringing the position to 32,881 shares worth $8.35M. The position accounts for 1.81% of the portfolio, ranked #10.

Generali Investments Management first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 1,021 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Generali Investments Management held 32,881 shares of Johnson & Johnson worth $8.35M as of Q2 2026.
  • Generali Investments Management bought 3,127 Johnson & Johnson shares in Q2 2026, an estimated $729K.
  • Johnson & Johnson made up 1.81% of Generali Investments Management's portfolio in Q2 2026, its #10 holding.
  • Generali Investments Management first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 1,021 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Generali Investments Management's 13F filing for Q2 2026, filed 10 Jul 2026.